PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 16.48.
Share Price | ₹5,259.4 | Apr 02,2025 |
Market Cap | ₹8,730.5 Cr | |
Book Value | ₹529.7 Cr | Jun2024 - Standalone Results |
Price/Book | 16.48x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹8,730.5 Cr] as on Apr 02,2025
(/) Book Value [ ₹529.7 Cr] based on Jun2024 - Standalone Results
(=) P/B Ratio [ 16.48x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '16.48 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Jun2024 to Jun2020 averaged 11.94x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 11.73x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Jun2024 at 15.83x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2020 of 7.47x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 529.71 | 16.48 | 8,730.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.46 | 411,306.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.08 | 150,343.0 |
CIPLA LTD | 26,619.90 | 4.41 | 117,323.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.84 | 108,619.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.41 | 95,941.5 |
MANKIND PHARMA LTD | 9,339.84 | 10.70 | 99,891.5 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.52 | 89,680.6 |
LUPIN LTD | 14,175.80 | 6.47 | 91,742.2 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.25 | 67,294.6 |
ABBOTT INDIA LTD | 3,658.73 | 17.18 | 62,839.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.25x |
Max industry PB | 17.18x |
Median industry PB | 6.47x |
Average industry PB | 8.98x |
You may also like the below Video Courses